$JNJ Preliminary Results from Phase 2 GALAHAD Study in Adults with Metastatic CastrationResistant Prostate Cancer and DNARepair Pathway Defects DRD httpswww.prnewswire.comnewsreleasesjanssenannouncespreliminaryresultsfromphase2galahadstu

$JNJ Preliminary Results from Phase 2 GALAHAD Study in Adults with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Pathway Defects (DRD) https://www.prnewswire.com/news-releases/janssen-announces-preliminary-results-from-phase-2-galahad-stu

08:02 EST 14 Feb 2019 | Odi Bruckman

$JNJ Preliminary Results from Phase 2 GALAHAD Study in Adults with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Pathway Defects (DRD) https://www.prnewswire.com/news-releases/janssen-announces-preliminary-results-from-phase-2-galahad-study-in-adults-with-metastatic-castration-resistant-prostate-cancer-and-dna-repair-pathway-defects-drd-300795836.html …

More From BioPortfolio on "$JNJ Preliminary Results from Phase 2 GALAHAD Study in Adults with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Pathway Defects (DRD) https://www.prnewswire.com/news-releases/janssen-announces-preliminary-results-from-phase-2-galahad-stu"